Psst! There’s a super-fast way to get beautiful hair-free skin

Revolutionise your beauty regime with SmoothSkin Bare – the latest in IPL technology

Promotional Feature

The temperature may have plummeted but party season is fast approaching and if you’re planning on going bare-legged or channelling an off-the-shoulder anything, you’ll want your skin to look and feel its best.

Along with the standard winter skin prep – exfoliate, scrub and moisturise – removing unwanted hair from your legs or underarms for a smooth and silky finish may also be on your to-do list. But with so many hair removal options out there, where do you begin?

Our latest discovery is SmoothSkin Bare, £199 – a super-sleek IPL device that’s ultra-fast and allows you to do a whole-body hair removal treatment in just 10 speedy minutes, so it’s easy to work into your weekly maintenance routine.

We’ve done the maths and this means there’s potential to lather on an intensive hair mask, give yourself a quick mani and remove any unwanted hair, all within half an hour. Is SmoothSkin Bare convenient? Yes. Effective? Indeed. And did we mention... it’s incredibly easy to use.

So why all the hype? The super-sleek device uses IPL technology to break the hair cycle and prevent regrowth, delivering up to 92% hair reduction after just four weeks of use*. To put it simply, light energy is absorbed by the hair follicle which heats up and stops the hairs from growing back. Best of all, it’s ultra-fast, producing 100 flashes per minute, which makes SmoothSkin Bare the quickest IPL device on the market.

Unlimited flashes means you’ll never need to worry that your SmoothSkin Bare will run out and you can use it on sensitive areas like your underarms, face and even your bikini line. Suitable for most skin tones and hair colours, its built-in technology checks your skin tone and will only activate if it’s safe, making sure you get the smoothest possible finish.

To find out more about SmoothSkin Bare and how it could work for your skin type, visit smoothskin.com

*Results of top 10% of participants of an independently approved clinical study.